a developer of biopharmaceutical products
Industry PharmaceuticalsOther
A.I.dvisor tells us that ESPR and ORGO have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESPR and ORGO's prices will move in lockstep.
Ticker / NAME | Correlation To ESPR | 1D Price Change % | ||
---|---|---|---|---|
ESPR | 100% | -5.83% | ||
ORGO - ESPR | 32% Poorly correlated | -9.59% | ||
CTLT - ESPR | 31% Poorly correlated | -0.41% | ||
SCYX - ESPR | 29% Poorly correlated | -2.33% | ||
EVO - ESPR | 26% Poorly correlated | +12.09% | ||
PAHC - ESPR | 25% Poorly correlated | -1.46% | ||
More |
Ticker / NAME | Correlation To ESPR | 1D Price Change % |
---|---|---|
ESPR | 100% | -5.83% |
drugs theme (254 stocks) | 35% Loosely correlated | -1.67% |
biopharmaceuticals theme (50 stocks) | 35% Loosely correlated | -2.60% |
biotechnology theme (238 stocks) | 33% Loosely correlated | -1.76% |
Pharmaceuticals: Other theme (235 stocks) | 18% Poorly correlated | -1.52% |
Pharmaceuticals theme (308 stocks) | 18% Poorly correlated | -1.29% |